ALBORGHETTI, MARIKA
ALBORGHETTI, MARIKA
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study
2023 De Carolis, Lanfranco; Galli, Silvia; Bianchini, Edoardo; Rinaldi, Domiziana; Raju, Manikandan; Caliò, Bianca; Alborghetti, Marika; Pontieri, Francesco E.
Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism
2023 Di Menna, Luisa; Orlando, Rosamaria; D'Errico, Giovanna; Ginerete, Roxana Paula; Machaczka, Agata; Bonaccorso, Carmela Maria; Arena, Andrea; Spatuzza, Michela; Celli, Roberta; Alborghetti, Marika; Ciocca, Eleonora; Zuena, Anna Rita; Scioli, Mariarosaria; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando; Catania, Maria Vincenza
Different generations of type-b monoamine oxidase inhibitors in parkinson’s disease: From bench to bedside
2019 Alborghetti, M.; Nicoletti, F.
Drug Choices and Advancements for Managing Depression in Parkinson`s Disease
2020 Assogna, Francesca; Pellicano, Clelia; Savini, Cinzia; Macchiusi, Lucia; Pellicano, Gaia R; Alborghetti, Marika; Caltagirone, Carlo; Spalletta, Gianfranco; Pontieri, Francesco E
Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint
2021 Alborghetti, Marika; Bellucci, Gianmarco; Gentile, Antonietta; Calderoni, Chiara; Nicoletti, Ferdinando; Capra, Ruggero; Salvetti, Marco; Centonze, Diego
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
2022 Bianchini, Edoardo; Onelli, Camilla; Morabito, Carmen; Alborghetti, Marika; Rinaldi, Domiziana; Anibaldi, Paolo; Marcolongo, Adriano; Salvetti, Marco; Pontieri, Francesco E.
Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
2023 Bianchini, Edoardo; Galli, Silvia; Alborghetti, Marika; DE CAROLIS, Lanfranco; Zampogna, Alessandro; Hansen, Clint; Vuillerme, Nicolas; Suppa, Antonio; Pontieri, Francesco E.
Metabotropic glutamate receptors type 3 and 5 feature the “NeuroTransmitter-type” of glioblastoma: a bioinformatic approach
2024 Caridi, Matteo; Alborghetti, Marika; Pellicelli, Valeria; Orlando, Rosamaria; Pontieri, Francesco Ernesto; Battaglia, Giuseppe; Arcella, Antonietta
Monoamine-Oxidase type B- Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action
2022 Rinaldi, Domiziana; Alborghetti, Marika; Bianchini, Edoardo; Sforza, Michela; Galli, Silvia; Pontieri, Francesco E
Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and Clinical Variables
2022 Bianchini, Edoardo; Caliò, Bianca; Alborghetti, Marika; Rinaldi, Domiziana; Hansen, Clint; Vuillerme, Nicolas; Maetzler, Walter; Pontieri, Francesco E.
Switch from rasagiline to safinamide in fluctuating Parkinson’s disease patients. a retrospective, pilot study
2021 Bianchini, E.; Sforza, M.; Rinaldi, D.; Alborghetti, M.; De Carolis, L.; Della Gatta, F.; Pontieri, F. E.
The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice
2021 Di Menna, L.; Busceti, C. L.; Ginerete, R. P.; D'Errico, G.; Orlando, R.; Alborghetti, M.; Bruno, V.; Battaglia, G.; Fornai, F.; Leoni, L.; Rampioni, G.; Visca, P.; Monn, J. A.; Nicoletti, F.
The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson’s Disease
2024 Bianchini, Edoardo; Rinaldi, Domiziana; Alborghetti, Marika; Simonelli, Marta; D’Audino, Flavia; Onelli, Camilla; Pegolo, Elena; Pontieri, Francesco E.
The tolerability, safety and efficacy of safinamide in elderly Parkinson's disease patients: a retrospective study
2020 Rinaldi, D; Bianchini, E; Sforza, M; Alborghetti, M; Galli, S; Salvetti, M; Giovannelli, M; Pontieri, Fe.
Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings
2023 Alborghetti, Marika; Bianchini, Edoardo; De Carolis, Lanfranco; Galli, Silvia; Pontieri, Francesco E.; Rinaldi, Domiziana
Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia
2023 Imbriglio, Tiziana; Alborghetti, Marika; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando; Cannella, Milena
Validation of the Canadian occupational performance measure in Italian Parkinson’s disease clients
2021 Bianchini, Edoardo; Della Gatta, Francesco; Virgilio, Miriam; Alborghetti, Marika; Salvetti, Marco; Giubilei, Franco; Pontieri, Francesco E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study | 2023 | De Carolis, Lanfranco; Galli, Silvia; Bianchini, Edoardo; Rinaldi, Domiziana; Raju, Manikandan; Caliò, Bianca; Alborghetti, Marika; Pontieri, Francesco E. | |
| Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism | 2023 | Di Menna, Luisa; Orlando, Rosamaria; D'Errico, Giovanna; Ginerete, Roxana Paula; Machaczka, Agata; Bonaccorso, Carmela Maria; Arena, Andrea; Spatuzza, Michela; Celli, Roberta; Alborghetti, Marika; Ciocca, Eleonora; Zuena, Anna Rita; Scioli, Mariarosaria; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando; Catania, Maria Vincenza | |
| Different generations of type-b monoamine oxidase inhibitors in parkinson’s disease: From bench to bedside | 2019 | Alborghetti, M.; Nicoletti, F. | |
| Drug Choices and Advancements for Managing Depression in Parkinson`s Disease | 2020 | Assogna, Francesca; Pellicano, Clelia; Savini, Cinzia; Macchiusi, Lucia; Pellicano, Gaia R; Alborghetti, Marika; Caltagirone, Carlo; Spalletta, Gianfranco; Pontieri, Francesco E | |
| Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint | 2021 | Alborghetti, Marika; Bellucci, Gianmarco; Gentile, Antonietta; Calderoni, Chiara; Nicoletti, Ferdinando; Capra, Ruggero; Salvetti, Marco; Centonze, Diego | |
| Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease | 2022 | Bianchini, Edoardo; Onelli, Camilla; Morabito, Carmen; Alborghetti, Marika; Rinaldi, Domiziana; Anibaldi, Paolo; Marcolongo, Adriano; Salvetti, Marco; Pontieri, Francesco E. | |
| Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch | 2023 | Bianchini, Edoardo; Galli, Silvia; Alborghetti, Marika; DE CAROLIS, Lanfranco; Zampogna, Alessandro; Hansen, Clint; Vuillerme, Nicolas; Suppa, Antonio; Pontieri, Francesco E. | |
| Metabotropic glutamate receptors type 3 and 5 feature the “NeuroTransmitter-type” of glioblastoma: a bioinformatic approach | 2024 | Caridi, Matteo; Alborghetti, Marika; Pellicelli, Valeria; Orlando, Rosamaria; Pontieri, Francesco Ernesto; Battaglia, Giuseppe; Arcella, Antonietta | |
| Monoamine-Oxidase type B- Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action | 2022 | Rinaldi, Domiziana; Alborghetti, Marika; Bianchini, Edoardo; Sforza, Michela; Galli, Silvia; Pontieri, Francesco E | |
| Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and Clinical Variables | 2022 | Bianchini, Edoardo; Caliò, Bianca; Alborghetti, Marika; Rinaldi, Domiziana; Hansen, Clint; Vuillerme, Nicolas; Maetzler, Walter; Pontieri, Francesco E. | |
| Switch from rasagiline to safinamide in fluctuating Parkinson’s disease patients. a retrospective, pilot study | 2021 | Bianchini, E.; Sforza, M.; Rinaldi, D.; Alborghetti, M.; De Carolis, L.; Della Gatta, F.; Pontieri, F. E. | |
| The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice | 2021 | Di Menna, L.; Busceti, C. L.; Ginerete, R. P.; D'Errico, G.; Orlando, R.; Alborghetti, M.; Bruno, V.; Battaglia, G.; Fornai, F.; Leoni, L.; Rampioni, G.; Visca, P.; Monn, J. A.; Nicoletti, F. | |
| The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson’s Disease | 2024 | Bianchini, Edoardo; Rinaldi, Domiziana; Alborghetti, Marika; Simonelli, Marta; D’Audino, Flavia; Onelli, Camilla; Pegolo, Elena; Pontieri, Francesco E. | |
| The tolerability, safety and efficacy of safinamide in elderly Parkinson's disease patients: a retrospective study | 2020 | Rinaldi, D; Bianchini, E; Sforza, M; Alborghetti, M; Galli, S; Salvetti, M; Giovannelli, M; Pontieri, Fe. | |
| Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings | 2023 | Alborghetti, Marika; Bianchini, Edoardo; De Carolis, Lanfranco; Galli, Silvia; Pontieri, Francesco E.; Rinaldi, Domiziana | |
| Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia | 2023 | Imbriglio, Tiziana; Alborghetti, Marika; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando; Cannella, Milena | |
| Validation of the Canadian occupational performance measure in Italian Parkinson’s disease clients | 2021 | Bianchini, Edoardo; Della Gatta, Francesco; Virgilio, Miriam; Alborghetti, Marika; Salvetti, Marco; Giubilei, Franco; Pontieri, Francesco E. |